Revision 1

#30774Store at -20C

Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Applications:

WB, IP

REACTIVITY:

H Mk

SENSITIVITY:

Endogenous

MW (kDa):

110, 135

Source/Isotype:

Rabbit IgG

UniProt ID:

#P98175

Entrez-Gene Id:

8241

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunoprecipitation 1:100

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

RBM10 (E6I1R) Rabbit mAb recognizes endogenous levels of total RBM10 protein. The antibody detects a 30 kDa protein of unknown origin.

Species Reactivity:

Human, Monkey

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly53 of human RBM10 protein.

Background

RBM10 is an RNA binding protein and a paralog to tumor suppressor RBM5 (1,2). Alternative splicing creates two highly expressed variants that differ by one exon. RBM10 controls alternative splicing and exon skipping of mRNAs, including Fas and Bcl-x (3,4). RBM10 has been shown to affect apoptosis via up regulation of TNF-α mRNA (5). In lung cancer, RBM10 mutations disrupt the splicing of NUMB, a regulator of Notch signaling (6,7). Fusion of the RBM10 gene with TFE3 has been found in renal cell carcinoma (8-9). Mutations of RBM10 causes TARP syndrome, an x-linked, lethal disorder characterized by various developmental defects (10-12).

  1. Timmer, T. et al. (1999) Genomics 60, 238-40.
  2. Bonnal, S. et al. (2008) Mol Cell 32, 81-95.
  3. Wang, Y. et al. (2013) EMBO Mol Med 5, 1431-42.
  4. Inoue, A. et al. (2014) FEBS Lett 588, 942-7.
  5. Wang, K. et al. (2012) J Cell Death 5, 1-19.
  6. Bechara, E.G. et al. (2013) Mol Cell 52, 720-33.
  7. Hernández, J. et al. (2016) RNA Biol 13, 466-72.
  8. Just, P.A. et al. (2016) Genes Chromosomes Cancer 55, 541-8.
  9. Argani, P. et al. (2017) Am J Surg Pathol 41, 655-62.
  10. Gorlin, R.J. et al. (1970) Am J Dis Child 119, 176-8.
  11. Johnston, J.J. et al. (2010) Am J Hum Genet 86, 743-8.
  12. Gripp, K.W. et al. (2011) Am J Med Genet A 155A, 2516-20.

Species Reactivity

Species reactivity is determined by testing in at least one approved application (e.g., western blot).

Western Blot Buffer

IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.

Applications Key

WB: Western Blotting IP: Immunoprecipitation

Cross-Reactivity Key

H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected

Trademarks and Patents

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
CST is a registered trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

Revision 1
#30774

RBM10 (E6I1R) Rabbit mAb

Western Blotting Image 1: RBM10 (E6I1R) Rabbit mAb Expand Image
Western blot analysis of extracts from A-673, MIA PaCa-2, and Caki-1 cells using RBM10 (E6I1R) Rabbit mAb (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower). As expected, Caki-1 cells are lower for RBM10 expression.
Immunoprecipitation Image 1: RBM10 (E6I1R) Rabbit mAb Expand Image
Immunoprecipitation of RBM10 protein from A-673 cell extracts. Lane 1 is 10% input, lane 2 is Rabbit (DA1E) mAb IgG XP® Isotype Control #3900, and lane 3 is RBM10 (E6I1R) Rabbit mAb. Western blot analysis was performed using RBM10 (E6I1R) Rabbit mAb. Anti-rabbit IgG, HRP-linked Antibody #7074 was used as a secondary antibody.